Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors : synthesis and inhibitory profile. / Sharonova, Tatiana; Zhmurov, Petr; Kalinin, Stanislav; Nocentini, Alessio; Angeli, Andrea; Ferraroni, Marta; Korsakov, Mikhail; Supuran, Claudiu T.; Krasavin, Mikhail.
в: Journal of Enzyme Inhibition and Medicinal Chemistry, Том 37, № 1, 16.03.2022, стр. 857-865.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors
T2 - synthesis and inhibitory profile
AU - Sharonova, Tatiana
AU - Zhmurov, Petr
AU - Kalinin, Stanislav
AU - Nocentini, Alessio
AU - Angeli, Andrea
AU - Ferraroni, Marta
AU - Korsakov, Mikhail
AU - Supuran, Claudiu T.
AU - Krasavin, Mikhail
N1 - Publisher Copyright: © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022/3/16
Y1 - 2022/3/16
N2 - A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments.
AB - A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments.
KW - Carbonic anhydrase
KW - co-operative fragment screening
KW - solubility
KW - sulfamides
KW - zinc-binding groups
KW - Humans
KW - Structure-Activity Relationship
KW - Drug Discovery
KW - Dose-Response Relationship, Drug
KW - Carbonic Anhydrase Inhibitors/chemical synthesis
KW - Carbonic Anhydrases/metabolism
KW - Molecular Structure
KW - Sulfonamides/chemical synthesis
KW - Isoenzymes/antagonists & inhibitors
KW - DESIGN
KW - SULFONAMIDES
KW - OF-THE-ART
KW - FAMOTIDINE
KW - ISOZYME-II
UR - http://www.scopus.com/inward/record.url?scp=85126648518&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/d1d8281d-b314-3daf-abe0-c6e8fd57ccf0/
U2 - 10.1080/14756366.2022.2051023
DO - 10.1080/14756366.2022.2051023
M3 - Article
C2 - 35296197
AN - SCOPUS:85126648518
VL - 37
SP - 857
EP - 865
JO - Journal of Enzyme Inhibition and Medicinal Chemistry
JF - Journal of Enzyme Inhibition and Medicinal Chemistry
SN - 1475-6366
IS - 1
ER -
ID: 94010611